Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'zd 7155 hydrochloride'

Search results for: 'zd 7155 hydrochloride'

Items 51-60 of 63

Page
per page
  1. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  2. Tizanidine HCl
    B1368 Tizanidine HCl
    Summary: α2-adrenergic receptor agonist
      ≥14.51 mg/mL
  3. Ondansetron HCl
    A5166 Ondansetron HCl
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥33.04 mg/mL
  4. Phenformin HCl
    B1373 Phenformin HCl
     1 Citation
    Target: AMPK
    Summary: biguanidine drug with anti-diabetic activity
      ≥12.1 mg/mL
  5. Butenafine HCl
    B1901 Butenafine HCl
    Target: Squalene epoxidases
    Summary: synthetic benzylamine antifungal
      insoluble in H2O; ≥17.55 mg/mL
  6. Naratriptan
    B2251 Naratriptan
    Target: 5-HT1 Receptor
    Summary: selective 5-HT1 receptor subtype agonist
      insoluble in H2O; ≥61.1 mg/mL
  7. Terbinafine HCl
    B2047 Terbinafine HCl
    Target: Squalene epoxidases
    Summary: Potent non-competitive inhibitor of squalene epoxidase
      insoluble in H2O; ≥16.3 mg/mL
  8. Dexmedetomidine HCl
    B1357 Dexmedetomidine HCl
    Summary: Highly selective and potent alpha-2 adrenoceptor agonist
      ≥126.2 mg/mL
  9. Benazepril HCl
    B2216 Benazepril HCl
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: angiotensin-converting enzyme (ACE) inhibitor
      ≥18.1 mg/mL
  10. Sevelamer Carbonate
    B1832 Sevelamer Carbonate
    Summary: Non-absorbed phosphate binding crosslinked polymer
      ≥24.25 mg/mL

Items 51-60 of 63

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 58item
  2. Natural Products 2item
  3. Lab Reagents 2item
Specificity
  1. Selective 37item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 1 item
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. mTOR 1 item
  9. Thymidine Phosphorylases 1 item
  10. GSK-3 1 item
  11. VEGFR 1 item
  12. PDGFR 1 item
  13. c-Kit 1 item
  14. Phosphodiesterases (PDEs) 2item
  15. Thymidylate Synthase 1 item
  16. p38 1 item
  17. GABAB Receptors 1 item
  18. Sir2-like Family Deacetylases (Sirtuins) 1 item
  19. Aminopeptidases 1 item
  20. EGFR 3item
  21. FAK 1 item
  22. Syk 1 item
  23. DNA-PK 1 item
  24. HSP90 1 item
  25. AMPK 1 item
  26. Topoisomerases 1 item
  27. Serine Proteases 1 item
  28. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  29. Pyk2 1 item
  30. 5-HT2 Receptors 2item
  31. ALK 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. 5-HT3 Receptors 2item
  34. Angiotensin-Converting Enzymes (ACEs) 1 item
  35. Squalene epoxidases 3item
  36. Nampt 1 item
  37. Glutamate (Metabotropic) Group I Receptors 1 item
  38. Histamine H1 Receptors 1 item
  39. Sigma Receptors 1 item
  40. AChE 1 item
  41. Inward Rectifier Potassium (Kir) Channels 1 item
  42. c-RET 1 item
  43. guanylyl cyclase 1 item
  44. dopamine receptor 1 item
  45. 5-HT1 Receptor 2item
  46. 5-HT2 Receptor 1 item
  47. NMPRTase 1 item
  48. IKK 1 item
  49. Antibiotic 1 item
  50. Calcium-Sensing Receptors (CaSRs) 2item
  51. TRPC channel 1 item
  52. GABAA receptor 1 item
  53. CRF1 Receptors 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 3item
  4. Breast Cancer 4item
  5. Cancer 20item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 2item
  8. Colorectal Cancer 4item
  9. Erectile Dysfunction 1 item
  10. Glioblastoma 3item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Liver Cancer 1 item
  15. Lung Cancer 2item
  16. Multidrug Resistance Studies 1 item
  17. Multiple Myeloma 2item
  18. Narcolepsy 1 item
  19. Non-small Cell Lung Cancer 1 item
  20. Ovarian Cancer 1 item
  21. Pancreatic Cancer 3item
  22. Prostate Cancer 4item
  23. Schizophrenia 1 item
  24. Type 2 Diabetes 1 item